Cited by 3,162Cancer Genomics and DiagnosticsCancer Cells and MetastasisEvolution and Genetic Dynamics

The DOI matches its Crossref record; 104 of the 107 references it cites were found in a registry or an index, and 3 are not checked yet.

Clonal evolution in cancer

Open access

Greaves, Mel, Maley, Carlo C.·2012·Nature

DOI 10.1038/nature10762PMC PMC3367003

Open this paper in CoChat — free account

Abstract

Cancers evolve by a reiterative process of clonal expansion, genetic diversification and clonal selection within the adaptive landscapes of tissue ecosystems. The dynamics are complex, with highly variable patterns of genetic diversity and resulting clonal architecture. Therapeutic intervention may destroy cancer clones and erode their habitats, but it can also inadvertently provide a potent selective pressure for the expansion of resistant variants. The inherently Darwinian character of cancer is the primary reason for this therapeutic failure, but it may also hold the key to more effective control.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature10762

Cites

104 of 107 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Cancer Statistics, 2008
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Tumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Yachida, S., Jones, S., Bozic, I., Antal, T., Leary, R., Fu, B., Kamiyama, M., Hruban, R. H., Eshleman, J. R., Nowak, M. A., et al. (2010) · Nature · doi:10.1038/nature09515 · Cited by 2,502
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Gupta, P. B., Önder, T. T., Jiang, G., Tao, K. X., Kuperwasser, C., Weinberg, R. A., & Lander, E. S. (2009) · Cell · doi:10.1016/j.cell.2009.06.034 · Cited by 2,429
Massive genomic rearrangement acquired in a single catastrophic event during cancer development
Stephens, P. J., Greenman, C. D., Fu, B., Yang, F., Bignell, G. R., Mudie, L. J., Pleasance, E. D., Lau, K. W., Beare, D., Stebbings, L. A., et al. (2011) · Cell · doi:10.1016/j.cell.2010.11.055 · Cited by 2,414
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253

Flagged first, then by citations

Show all 104 references

Sorted by citations

Items 201–300 of 1,004

Mechanisms of clonal evolution in childhood acute lymphoblastic leukemia
Swaminathan, S., Klemm, L., Park, E., Papaemmanuil, E., Ford, A. M., Kweon, S.-M., Trageser, D., Hasselfeld, B., Henke, N., Mooster, J. L., et al. (2015) · Nature Immunology · doi:10.1038/ni.3160 · Cited by 204
Self-citation
Cooperation among cancer cells: applying game theory to cancer
Archetti, M., & Pienta, K. J. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0083-7 · Cited by 203
Heterogeneous Tumor Subpopulations Cooperate to Drive Invasion
Chapman, A., del Ama, L. F., Ferguson, J., Kamarashev, J. A., Wellbrock, C., & Hurlstone, A. F. L. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.045 · Cited by 195
The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance
Januchowski, R., Wojtowicz, K., & Zabel, M. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.04.005 · Cited by 214
Modelling of compound combination effects and applications to efficacy and toxicity: state-of-the-art, challenges and perspectives
Bulusu, K. C., Guha, R., Mason, D. J., Lewis, R. P., Muratov, E. N., KalantarMotamedi, Y., Cokol, M., & Bender, A. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.09.003 · Cited by 208
The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells
Hu, Z., Artibani, M., Alsaadi, A., Wietek, N. C., Morotti, M., Shi, T., Zhong, Z., González, L. S., El-Sahhar, S., Carrami, E. M., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.01.003 · Cited by 195
Patterns of Stem Cell Divisions Contribute to Plant Longevity
Burian, A., de Reuille, P. B., & Kuhlemeier, C. J. (2016) · Current Biology · doi:10.1016/j.cub.2016.03.067 · Cited by 201
Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes
Meeks, J. J., Al‐Ahmadie, H. A., Faltas, B. M., Taylor, J. A., Flaig, T. W., DeGraff, D. J., Christensen, E., Woolbright, B. L., McConkey, D. J., & Dyrskjøt, L. (2020) · Nature Reviews Urology · doi:10.1038/s41585-020-0304-1 · Cited by 207
DNA template strand sequencing of single-cells maps genomic rearrangements at high resolution
Falconer, E., Hills, M., Naumann, U., Poon, S. S. S., Chavez, E. A., Sanders, A. D., Zhao, Y., Hirst, M., & Lansdorp, P. M. (2012) · Nature Methods · doi:10.1038/nmeth.2206 · Cited by 199
Clonal evolution of colorectal cancer in IBD
Choi, C.-H. R., Bakir, I. A., Hart, A. L., & Graham, T. A. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.1 · Cited by 202
Residue mutations and their impact on protein structure and function: detecting beneficial and pathogenic changes
Studer, R. A., Dessailly, B. H., & Orengo, C. A. (2013) · Biochemical Journal · doi:10.1042/bj20121221 · Cited by 202
Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells
Ahmed, S. U., Carruthers, R., Gilmour, L., Yildirim, S., Watts, C., & Chalmers, A. J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3790 · Cited by 203
Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis
Tellez-Gabriel, M., Ory, B., Lamoureux, F., Heymann, M., & Heymann, D. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122142 · Cited by 203
Tumor microenvironment enriches the stemness features: the architectural event of therapy resistance and metastasis
Nallasamy, P., Nimmakayala, R. K., Parte, S. C., Are, A. C., Batra, S. K., & Ponnusamy, M. P. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01682-x · Cited by 205
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions
Valent, P., Orazi, A., Steensma, D. P., Ebert, B. L., Haase, D. T., Malcovati, L., van de Loosdrecht, A. A., Haferlach, T., Westers, T. M., Wells, D. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19008 · Cited by 197
Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer
Coward, J. I. G., & Harding, A. S. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00123 · Cited by 197
Mutant clones in normal epithelium outcompete and eliminate emerging tumours
Colom, B., Herms, A., Hall, M. W. J., Dentro, S. C., King, C., Sood, R. K., Alcolea, M. P., Piedrafita, G., Fernandez-Antoran, D., Ong, S. H., et al. (2021) · Nature · doi:10.1038/s41586-021-03965-7 · Cited by 192
Tumour evolution and microenvironment interactions in 2D and 3D space
Mo, C.-K., Liu, J., Chen, S., Storrs, E. P., da Costa, A. L. N. T., Houston, A., Wendl, M. C., Jayasinghe, R. G., Iglesia, M. D., Ma, C., et al. (2024) · Nature · doi:10.1038/s41586-024-08087-4 · Cited by 198
Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features
Omori, Y., Ono, Y., Tanino, M. A., Karasaki, H., Yamaguchi, H., Furukawa, T., Enomoto, K., Ueda, J., Sumi, A., Katayama, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.029 · Cited by 189
Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance
Amend, S. R., Torga, G., Lin, K.-C., Kostecka, L. G., Marzo, A. D., Austin, R. H., & Pienta, K. J. (2019) · The Prostate · doi:10.1002/pros.23877 · Cited by 190
Collateral damage: Insights into bacterial mechanisms that predispose host cells to cancer
Gagnaire, A., Nadel, B., Raoult, D., Neefjes, J., & Gorvel, J.-P. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.171 · Cited by 189
Discovery of the cancer stem cell related determinants of radioresistance
Peitzsch, C., Kurth, I., Kunz‐Schughart, L. A., Baumann, M. A., & Dubrovska, A. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.003 · Cited by 195
Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer
Vallette, F. M., Olivier, C., Lézot, F., Oliver, L., Cochonneau, D., Lalier-Bretaudeau, L., Cartron, P., & Heymann, D. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.11.004 · Cited by 192
The tumour microenvironment and immune milieu of cholangiocarcinoma
Fabris, L., Perugorria, M. J., Mertens, J., Björkström, N. K., Cramer, T., Lleo, A., Solinas, A., Sänger, H., Lukacs‐Kornek, V., Moncsek, A., et al. (2019) · Liver International · doi:10.1111/liv.14098 · Cited by 187
Spatial genomics maps the structure, nature and evolution of cancer clones
Lomakin, A., Svedlund, J., Strell, C., Gatarić, M., Shmatko, A., Rukhovich, G. D., Park, J. S., Ju, Y. S., Dentro, S. C., Kleshchevnikov, V., et al. (2022) · Nature · doi:10.1038/s41586-022-05425-2 · Cited by 212
Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution
Heng, H. H., Bremer, S. W., Stevens, J. B., Horne, S. D., Liu, G., Abdallah, B. Y., Ye, K. J., & Ye, C. J. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9427-7 · Cited by 191
Data-driven identification of prognostic tumor subpopulations using spatially mapped t-SNE of mass spectrometry imaging data
Abdelmoula, W. M., Balluff, B., Englert, S., Dijkstra, J., Reinders, M. J. T., Walch, A. K., McDonnell, L. A., & Lelieveldt, B. P. F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510227113 · Cited by 184
Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation
Kandalaft, L. E., Laniti, D. D., & Coukos, G. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00503-z · Cited by 190
B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment
Polak, R., de Rooij, B., Pieters, R., & den Boer, M. L. (2015) · Blood · doi:10.1182/blood-2015-03-634238 · Cited by 188
Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies
Du, W., & Elemento, O. (2014) · Oncogene · doi:10.1038/onc.2014.291 · Cited by 185
Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy
CASTILHO, R. M., SQUARIZE, C. H., & Almeida, L. O. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071506 · Cited by 187
Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium
Aldape, K., Amin, S. B., Ashley, D. M., Barnholtz‐Sloan, J. S., Bates, A. J., Beroukhim, R., Bock, C., Brat, D. J., Claus, E. B., Costello, J., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy020 · Cited by 179
Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress
Olivier, C., Oliver, L., Lalier-Bretaudeau, L., & Vallette, F. M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.620677 · Cited by 191
Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
Grove, C. S., & Vassiliou, G. S. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.015974 · Cited by 202
Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma
Torrecilla, S., Sia, D., Harrington, A., Zhang, Z., Cabellos, L., Cornellà, H., Moeini, A., Campreciós, G., Leow, W. Q., Fiel, M. I., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.013 · Cited by 184
Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation
Afify, S. M., & Seno, M. (2019) · Cancers · doi:10.3390/cancers11030345 · Cited by 188
A Carcinogen-induced mouse model recapitulates the molecular alterations of human muscle invasive bladder cancer
Fantini, D., Glaser, A. P., Rimar, K. J., Wang, Y., Schipma, M. J., Varghese, N., RADEMAKER, A. W., Behdad, A., Yellapa, A., Yu, Y., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0099-6 · Cited by 179
Bimodal Tumor-Targeting from Microenvironment Responsive Hyaluronan Layer-by-Layer (LbL) Nanoparticles
Dreaden, E. C., Morton, S. W., Shopsowitz, K. E., Choi, J.-H., Deng, Z. J., Cho, N.-J., & Hammond, P. T. (2014) · ACS Nano · doi:10.1021/nn502861t · Cited by 179
The multifaceted regulation and functions of PKM2 in tumor progression
Li, Z., Yang, P., & Li, Z. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.07.008 · Cited by 175
Targeting ALK in neuroblastoma—preclinical and clinical advancements
Carpenter, E. L., & Mossé, Y. P. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.72 · Cited by 177
Stress-Induced Mutagenesis: Implications in Cancer and Drug Resistance
Fitzgerald, D. M., Hastings, P. J., & Rosenberg, S. M. (2016) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050216-121919 · Cited by 178
Antibiotic collateral sensitivity is contingent on the repeatability of evolution
Nichol, D., Rutter, J., Bryant, C., Hujer, A. M., Lek, S., Adams, M. D., Jeavons, P., Anderson, A. R. A., Bonomo, R. A., & Scott, J. G. (2019) · Nature Communications · doi:10.1038/s41467-018-08098-6 · Cited by 174
Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile
Paiva, B., Paíno, T., Sayagués, J. M., Garayoa, M., San‐Segundo, L., Martín, M., Mota, I. A., Sánchez, M.-L., Bárcena, P., Aires‐Mejía, I., et al. (2013) · Blood · doi:10.1182/blood-2013-06-510453 · Cited by 181
Detecting repeated cancer evolution from multi-region tumor sequencing data
Caravagna, G., Giarratano, Y., Ramazzotti, D., Tomlinson, I. P. M., Graham, T. A., Sanguinetti, G., & Sottoriva, A. (2018) · Nature Methods · doi:10.1038/s41592-018-0108-x · Cited by 162
Single-cell sequencing data reveal widespread recurrence and loss of mutational hits in the life histories of tumorsPreprint
Kuipers, J., Jahn, K., Raphael, B. J., & Beerenwinkel, N. (2017) · Genome Research · doi:10.1101/gr.220707.117 · Cited by 168
High-Definition Reconstruction of Clonal Composition in Cancer
Fischer, A., Vázquez-Garćıa, I., Illingworth, C. J. R., & Mustonen, V. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.055 · Cited by 166
Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications
Paul, R., Dorsey, J. F., & Fan, Y. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107985 · Cited by 170
Elimination of Unfit Cells Maintains Tissue Health and Prolongs Lifespan
Merino, M. M., Rhiner, C., López-Gay, J. M., Buechel, D., Hauert, B., & Moreno, E. (2015) · Cell · doi:10.1016/j.cell.2014.12.017 · Cited by 174
Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
Gote, V., Nookala, A. R., Bolla, P. K., & Pal, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094673 · Cited by 182
Clonal evolution in hematological malignancies and therapeutic implications
Landau, D. A., Carter, S. L., Getz, G. A., & Wu, C. J. (2013) · Leukemia · doi:10.1038/leu.2013.248 · Cited by 173
TMB: a promising immune-response biomarker, and potential spearhead in advancing targeted therapy trials
Choucair, K., Morand, S. M., Stanbery, L., Edelman, G. M., Dworkin, L. D., & Nemunaitis, J. J. (2020) · Cancer Gene Therapy · doi:10.1038/s41417-020-0174-y · Cited by 170
Boolean Network Model for Cancer Pathways: Predicting Carcinogenesis and Targeted Therapy Outcomes
Fumiã, H. F., & Martins, M. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069008 · Cited by 172
Multiregional single-cell dissection of tumor and immune cells reveals stable lock-and-key features in liver cancer
Ma, L., Heinrich, S., Wang, L., Keggenhoff, F. L., Khatib, S. A., Forgues, M., Kelly, M. C., Hewitt, S. M., Saif, A., Hernandez, J. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35291-5 · Cited by 178
Evolutionary medicine: its scope, interest and potential
Stearns, S. C. (2012) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2012.1326 · Cited by 163
Genetic insights into the morass of metastatic heterogeneity
Hunter, K. W., Amin, R., Deasy, S. K., Ha, N., & Wakefield, L. M. (2018) · Nature reviews. Cancer · doi:10.1038/nrc.2017.126 · Cited by 167
Metronomic chemotherapy and immunotherapy in cancer treatment
Chen, Y., Chang, M.-C., & Cheng, W. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.040 · Cited by 167
Pancreatic Cancer Genomes: Implications for Clinical Management and Therapeutic Development
Dreyer, S. B., Chang, D. K.-F., Bailey, P. J., & Biankin, A. V. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2411 · Cited by 168
Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia
Paguirigan, A. L., Smith, J. L., Meshinchi, S., Carroll, M. P., Maley, C. C., & Radich, J. P. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa0763 · Cited by 159
Self-citation
Subclonal Genomic Architectures of Primary and Metastatic Colorectal Cancer Based on Intratumoral Genetic Heterogeneity
Kim, T., Jung, S., An, C. H., Lee, S. H., Baek, I.-P., Kim, M. S., Park, S., Rhee, J., Lee, S.-H., & Chung, Y. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2413 · Cited by 161
ZIC2-dependent OCT4 activation drives self-renewal of human liver cancer stem cells
Zhu, P., Wang, Y., He, L., Huang, G., Du, Y., Zhang, G., Yan, X., Xia, P., Ye, B., Wang, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81979 · Cited by 157
A neuronal network of mitochondrial dynamics regulates metastasis
Caino, M. C., Seo, J. H., Aguinaldo, A., Wait, E. C., Bryant, K. G., Kossenkov, A. V., Hayden, J. E., Vaira, V., Morotti, A., Ferrero, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms13730 · Cited by 162
Longitudinal single-cell RNA sequencing of patient-derived primary cells reveals drug-induced infidelity in stem cell hierarchy
Sharma, A., Cao, E. Y., Kumar, V., Zhang, X., Leong, H. S., Wong, A. M. L., Ramakrishnan, N., Hakimullah, M., Teo, H. M. V., Chong, F. T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07261-3 · Cited by 159
Experimental evolution in biofilm populations
Steenackers, H. P. L., Parijs, I., Foster, K. R., & Vanderleyden, J. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw002 · Cited by 156
Potential clinical utility of liquid biopsies in ovarian cancer
Zhu, J. W., Charkhchi, P., & Akbari, M. R. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01588-8 · Cited by 166
Heterogeneity for IGF-II production maintained by public goods dynamics in neuroendocrine pancreatic cancer
Archetti, M., Ferraro, D. A., & Christofori, G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414653112 · Cited by 154
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer
Luca, F. D., Rotunno, G., Salvianti, F., Galardi, F., Pestrin, M., Gabellini, S., Simi, L., Mancini, I., Vannucchi, A. M., Pazzagli, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8431 · Cited by 157
In silico polypharmacology of natural products
Fang, J., Liu, C., Wang, Q., Lin, P., & Cheng, F. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx045 · Cited by 168
Circulating Tumor Cells Dynamics in Pancreatic Adenocarcinoma Correlate With Disease Status
Gemenetzis, G., Groot, V. P., Yu, J., Ding, D., Teinor, J. A., Javed, A. A., Wood, L. D., Burkhart, R. A., Cameron, J. L., Makary, M. A., et al. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002925 · Cited by 161
Seipin: from human disease to molecular mechanism
Cartwright, B. R., & Goodman, J. M. (2012) · Journal of Lipid Research · doi:10.1194/jlr.r023754 · Cited by 160
SiFit: inferring tumor trees from single-cell sequencing data under finite-sites models
Zafar, H., Tzen, A., Navin, N. E., Chen, K., & Nakhleh, L. K. (2017) · Genome biology · doi:10.1186/s13059-017-1311-2 · Cited by 156
Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression
Yang, H. H., & Lin, P. C. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.001 · Cited by 157
3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments
Albritton, J. L., & Miller, J. S. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.025049 · Cited by 154
Metabolic Adaptations in Cancer Stem Cells
Yadav, U. P., Singh, T., Kumar, P., Sharma, P., Kaur, H., Sharma, S., Singh, S., Kumar, S., & Mehta, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01010 · Cited by 158
Nonsense-mediated RNA decay: an emerging modulator of malignancy
Tan, K., Stupack, D. G., & Wilkinson, M. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00481-2 · Cited by 154
The renaissance of polypharmacology in the development of anti-cancer therapeutics: Inhibition of the “Triad of Death” in cancer by Di-2-pyridylketone thiosemicarbazones
Jansson, P. J., Kalinowski, D. S., Lane, D. J. R., Kovačević, Ž., Seebacher, N. A., Fouani, L., Sahni, S., Merlot, A. M., & Richardson, D. R. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.08.013 · Cited by 151
Advances in understanding tumour evolution through single-cell sequencing
Kuipers, J., Jahn, K., & Beerenwinkel, N. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.02.001 · Cited by 148
Angiogenesis and the Tumor Microenvironment: Vascular Endothelial Growth Factor and Beyond
Mittal, K., Ebos, J. M. L., & Rini, B. I. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.02.007 · Cited by 153
Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution
Venkatesan, S., Rosenthal, R., Kanu, N., McGranahan, N., Bártek, J., Quezada, S. A., Hare, J., Harris, R. S., & Swanton, C. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy003 · Cited by 155
Multiregion Sequencing Reveals the Genetic Heterogeneity and Evolutionary History of Osteosarcoma and Matched Pulmonary Metastases
Wang, D., Niu, X., Wang, Z., Song, C., Huang, Z., Chen, K., Duan, J., Bai, H., Xu, J., Zhao, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1086 · Cited by 149
Cancer stem cell targeted therapy: progress amid controversies
Wang, T., Shigdar, S. L., Gantier, M. P., Hou, Y., Wang, L., Li, Y., Shamaileh, H. A., Yin, W., Zhou, S., Zhao, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6176 · Cited by 150
Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells
Melzer, C., von der Ohe, J., Lehnert, H., Ungefroren, H., & Hass, R. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0595-x · Cited by 152
The dualistic origin of human tumors
Liu, J. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.004 · Cited by 148
GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft
Fu, J., Rodova, M., Roy, S. K., Sharma, J. P., Singh, K. P., Srivastava, R. K., & Shankar, S. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.018 · Cited by 148
Temporal and Spatial Evolution of Somatic Chromosomal Alterations: A Case-Cohort Study of Barrett's Esophagus
Li, X., Galipeau, P. C., Paulson, T. G., Sanchez, C. A., Arnaudo, J., Liu, K., Sather, C. L., Kostadinov, R. L., Odze, R. D., Kuhner, M. K., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0289 · Cited by 144
Self-citation
Predictive Modeling of Influenza Shows the Promise of Applied Evolutionary Biology
Morris, D. H., Gostic, K. M., Pompei, S., Bedford, T., Łuksza, M., Neher, R. A., Grenfell, B. T., Lässig, M., & McCauley, J. W. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.09.004 · Cited by 148
Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia
Guièze, R., & Wu, C. J. (2015) · Blood · doi:10.1182/blood-2015-02-585042 · Cited by 151
Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment
Garralda, E., Paz, K., Lopez-Casas, P. P., Jones, S., Katz, A. M., Kann, L. M., López‐Ríos, F., Sarno, F., Al‐Shahrour, F., Vasquez, D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3047 · Cited by 148
The reverse evolution from multicellularity to unicellularity during carcinogenesis
Chen, H., Lin, F., Xing, K., & He, X. (2015) · Nature Communications · doi:10.1038/ncomms7367 · Cited by 155
The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma
Zhai, W., Lim, T. K. H., Zhang, T., Phang, S.-T., Tiang, Z., Guan, P., Ng, M.-H., Lim, J. Q., Yao, F., Li, Z., et al. (2017) · Nature Communications · doi:10.1038/ncomms14565 · Cited by 145
Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation
Chisholm, R. H., Lorenzi, T., Lorz, A., Larsen, A. K., de Almeida, L. N., Escargueil, A. E., & Clairambault, J. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2103 · Cited by 149
The molecular and cellular origin of human prostate cancer
Packer, J. R., & Maitland, N. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.02.016 · Cited by 161
The genetic landscape of anaplastic pleomorphic xanthoastrocytoma
Phillips, J. J., Gong, H. Z., Chen, K. Y., Joseph, N. M., Ziffle, J. V., Bastian, B. C., Grenert, J. P., Kline, C., Mueller, S., Banerjee, A., et al. (2018) · Brain Pathology · doi:10.1111/bpa.12639 · Cited by 150
Characterizing the ecological and evolutionary dynamics of cancer
Zahir, N., Sun, R., Gallahan, D., Gatenby, R. A., & Curtis, C. N. (2020) · Nature Genetics · doi:10.1038/s41588-020-0668-4 · Cited by 144
Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA
Izumchenko, E., Chang, X., Brait, M., Fertig, E. J., Kagohara, L. T., Bedi, A., Marchionni, L., Agrawal, N., Ravi, R. K., Jones, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9258 · Cited by 148
Unraveling cell populations in tumors by single-cell mass cytometry
Palma, S. D., & Bodenmiller, B. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.07.004 · Cited by 145
Zebrafish: Speeding Up the Cancer Drug Discovery Process
Letrado, P., de Miguel, I., Lamberto, I., Díez‐Martínez, R., & Oyarzábal, J. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1029 · Cited by 152
PyClone-VI: scalable inference of clonal population structures using whole genome data
Gillis, S., & Roth, A. J. L. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03919-2 · Cited by 145
Effects of aneuploidy on cell behaviour and function
Li, R., & Zhu, J. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00436-9 · Cited by 147
Principles of Reconstructing the Subclonal Architecture of CancersPreprint
Dentro, S. C., Wedge, D. C., & Loo, P. V. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026625 · Cited by 141
Survival of the Fittest: Essential Roles of Cell Competition in Development, Aging, and Cancer
Merino, M. M., Levayer, R., & Moreno, E. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.05.009 · Cited by 154

Authors: Greaves, M., & Maley, C. C.
Affiliations: University of California, San Francisco (US)
ORCID: Maley, Carlo C.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2012-01
Volume: 481
Issue: 7381
Pages: 306-313
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature10762
PMC: PMC3367003
OpenAlex: W2023560061
Cited by: 3,162
References: 104
Citations by year: 2026: 180 · 2025: 160 · 2024: 181 · 2023: 225 · 2022: 204 · 2021: 253 · 2020: 229 · 2019: 211 · 2018: 247 · 2017: 296 · 2016: 247 · 2015: 238 · 2014: 221 · 2013: 164 · 2012: 101
FWCI: 17.27
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: National Cancer Institute (R01CA149566, P01CA091955, U54CA143803, P01CA91955, R01CA140657)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords: clonal evolution, cancer, clonal expansion, genetic diversification, clonal selection, fitness landscape, tumor microenvironment, clonal architecture, drug resistance
MeSH terms: Animals, Clone Cells, Humans, Mutation, Neoplasms, Neoplastic Stem Cells, Genomics, Tumor Microenvironment, Clonal Evolution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clonal evolution in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks